UBS Asset Management Americas Inc. increased its position in Omega Healthcare Investors Inc (NYSE:OHI) by 57.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,170,496 shares of the real estate investment trust’s stock after buying an additional 426,665 shares during the period. UBS Asset Management Americas Inc.’s holdings in Omega Healthcare Investors were worth $49,571,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. First Trust Advisors LP boosted its position in Omega Healthcare Investors by 139.6% during the 4th quarter. First Trust Advisors LP now owns 121,813 shares of the real estate investment trust’s stock valued at $5,159,000 after acquiring an additional 70,967 shares in the last quarter. Trustcore Financial Services LLC grew its position in Omega Healthcare Investors by 48.3% during the fourth quarter. Trustcore Financial Services LLC now owns 40,969 shares of the real estate investment trust’s stock worth $1,735,000 after buying an additional 13,349 shares during the period. Winslow Evans & Crocker Inc. grew its position in Omega Healthcare Investors by 48.6% during the fourth quarter. Winslow Evans & Crocker Inc. now owns 5,500 shares of the real estate investment trust’s stock worth $234,000 after buying an additional 1,800 shares during the period. ARP Americas LP grew its position in Omega Healthcare Investors by 39.8% during the fourth quarter. ARP Americas LP now owns 33,032 shares of the real estate investment trust’s stock worth $1,399,000 after buying an additional 9,400 shares during the period. Finally, Redpoint Investment Management Pty Ltd grew its position in Omega Healthcare Investors by 20.2% during the third quarter. Redpoint Investment Management Pty Ltd now owns 18,557 shares of the real estate investment trust’s stock worth $775,000 after buying an additional 3,117 shares during the period. Institutional investors own 74.46% of the company’s stock.

Shares of NYSE OHI traded up $0.87 during midday trading on Wednesday, hitting $26.11. The company’s stock had a trading volume of 4,011,187 shares, compared to its average volume of 2,559,145. Omega Healthcare Investors Inc has a 1-year low of $13.33 and a 1-year high of $45.22. The firm’s fifty day moving average price is $37.15 and its 200-day moving average price is $40.95. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.67 and a current ratio of 2.67. The firm has a market cap of $5.04 billion, a P/E ratio of 16.53, a P/E/G ratio of 3.28 and a beta of 0.49.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.27 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.37 by ($0.10). Omega Healthcare Investors had a net margin of 36.73% and a return on equity of 8.38%. The business had revenue of $212.18 million during the quarter, compared to analyst estimates of $204.40 million. During the same period last year, the firm posted $0.73 earnings per share. The company’s quarterly revenue was up 12.7% on a year-over-year basis. As a group, research analysts predict that Omega Healthcare Investors Inc will post 3.13 earnings per share for the current fiscal year.

OHI has been the topic of several research reports. Raymond James upgraded shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $30.00 price target on the stock in a research report on Wednesday. Mizuho initiated coverage on shares of Omega Healthcare Investors in a research report on Thursday, December 19th. They issued a “buy” rating and a $50.00 price target on the stock. Citigroup initiated coverage on shares of Omega Healthcare Investors in a research report on Wednesday, January 22nd. They issued a “neutral” rating and a $44.00 price target on the stock. Bank of America lowered shares of Omega Healthcare Investors from a “buy” rating to a “neutral” rating in a research report on Monday. Finally, Zacks Investment Research lowered shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research report on Tuesday, March 17th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $42.50.

In related news, Director Craig R. Callen purchased 5,000 shares of the business’s stock in a transaction on Monday, March 16th. The shares were bought at an average price of $17.68 per share, with a total value of $88,400.00. Also, insider Steven J. Insoft sold 50,000 shares of the stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $42.12, for a total transaction of $2,106,000.00. Following the transaction, the insider now directly owns 258,032 shares in the company, valued at approximately $10,868,307.84. The disclosure for this sale can be found here. Insiders have sold a total of 150,000 shares of company stock worth $6,480,500 over the last 90 days. Corporate insiders own 1.16% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Recommended Story: What is a management fee?

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors Inc (NYSE:OHI).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.